Ligand validation:3B06

DMA: DIMETHYLALLYL DIPHOSPHATE

DMA is a Ligand Of Interest in 3B06 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3B06_DMA_C_701	95%	40%	0.076	0.982	0.68	1.64	-	4	1	0	100%	1
3B06_DMA_B_701	94%	37%	0.082	0.98	0.61	1.83	-	4	1	0	100%	1
3B06_DMA_D_701	93%	29%	0.09	0.984	0.95	1.86	-	4	0	0	100%	1
3B06_DMA_A_701	92%	41%	0.092	0.983	0.89	1.39	-	2	2	0	100%	1
2ZRZ_DMA_D_701	87%	46%	0.109	0.982	0.63	1.44	-	3	0	0	100%	1
2ZRX_DMA_A_701	85%	53%	0.115	0.982	0.52	1.28	-	3	2	0	100%	1
7VQA_DMA_A_301	99%	58%	0.057	0.987	0.86	0.77	-	-	0	0	100%	1
5YNT_DMA_A_401	98%	50%	0.062	0.988	0.97	0.95	-	-	0	0	100%	1
3PDE_DMA_D_309	98%	50%	0.068	0.987	0.64	1.27	-	2	1	0	100%	1
4GP1_DMA_A_402	96%	35%	0.071	0.981	1.9	0.71	5	-	1	0	100%	1
3P41_DMA_A_300	94%	36%	0.079	0.979	0.6	1.86	-	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.